article thumbnail

Bacterial infection may be a “key event” in triggering endometriosis development

Pharmaceutical Technology

Based on these findings, GlobalData believes that the eradication of this bacterium by a non-hormonal antibiotic treatment may represent a promising approach to treating endometriosis for women who are positive for Fusobacteria infection, as well as for those women with endometriosis trying to conceive or who do not wish to use hormone treatments.

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

5) Ibrance (palbociclib) Ibrance is a chemotherapy drug indicated for hormone receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. It is a CDK 4/6 inhibitor that is taken in combination with other hormonal therapies to stop the growth of cancer and healthy cells. billion in 2022.

Sales 98